Humanigen Inc. (NASDAQ:HGEN) currently has a daily average trading volume of 1.38M but it saw 789096 shares traded on Wednesday. With a market cap of 17.79M USD, stock’s current market price of $0.15 came rising about 0.68 while comparing to the previous closing price of $0.15. In past 52 weeks, the stock remained buoying in the range of price level as high as $3.25 and as low as $0.09. In the recent trading on the day, stock has struck highest price mark of $0.1531 while lowest mark touched by it was $0.1488.
Top 5 EV Tech Stocks to Buy for 2023
According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.
Click Here to Download the FREE Report.
Sponsored
Taking a look at 20-day trading activity of Humanigen Inc. (HGEN) gives us an average price of $0.1568, while its current price level is -95.41% below from 52-week high level whereas it is 61.36% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $0.1527 while that of 200 days or SMA-200 reads an average of $0.1712. A closer look into the stock’s movement over the week reveals that its volatility is standing at 3.46% during that period while stretching the period over a month that increases to 7.48%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 45.95 which implies that the stock is in neutral territory.
Humanigen Inc. (HGEN)’s stock is currently under the radar of 2 analysts who are in consensus at a 12-month price target range of between $0.15 and $0.50 for company’s shares. The average price target assigned by the average number of analysts to a stock is a way to gauge worth of any stock in next 52 weeks. And in assigning price target to a stock, some analysts adopt a bearish approach by advocating lower-than-average price target which in this case is $0.15 while some adopt bullish approach by assigning higher-than-average price target which reads the price to top $0.50. Average price target assigned by them is $0.33 which highlights an upside potential of 54.55% for the stock over that period. And to attain the median price target of $0.33 assigned by those analysts, stock has to add about 54.55% of value to its current levels.
Data by FactSet Research shows that 2 analysts have issued their ratings for the stock. 1 of them are in opinions that stock is a Sell, while 0 are advising it as an Overweight. 0 analysts suggested the investors to Buy the stock while 1 advised them to Hold. Recommendations by all of those brokerages imply a consensus rating of Underweight for the stock and that issued by Wall Street to investors is Hold.
Over the week, HGEN’s stock price is moving -6.23% down while it is -9.64% when we observe its performance for the past one month. Year-to-date it is 24.25% up and over the past year, the stock is showing a downside performance of -93.03%.
The latest quarterly earnings report issued by the company was for quarter ended 3/30/2023, when its quarterly earnings per share (EPS) of -$0.04 beat the consensus estimate of -$0.06 for the same. The company is expected to be releasing its next quarterly report in 08/10/2023, for which analysts forecasted an EPS of -$0.04 while estimate for next year EPS is -$0.22. For HGEN, analysts are forecasting an EPS-growth rate of 72.20% for current year and estimate for EPS growth in next year is 68.20%.
Currently, Humanigen Inc.’s total number of outstanding shares is 119.08M with 10.51% of that held by the insiders while 5.88% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at 145.90%. Stock’s beta reads -0.87. Stock has a price to sale or P/S ratio amounts to 7.12.
